Literature DB >> 29191127

The association between the environmental endocrine disruptor bisphenol A and polycystic ovary syndrome: a systematic review and meta-analysis.

Ying Hu1,2, Shu Wen3, Dongzhi Yuan4, Le Peng5, Rujun Zeng1, Zhilan Yang1, Qi Liu3, Liangzhi Xu1, Deying Kang6.   

Abstract

OBJECTIVE: To investigate the association between bisphenol A (BPA) and polycystic ovary syndrome (PCOS).
METHODS: A systematic review and meta-analysis using STATA software for observational studies.
RESULTS: Nine studies involving 493 PCOS patients and 440 controls were included in this review. The meta-analysis demonstrated that PCOS patients had significantly higher BPA levels compared with control groups (standardized mean difference (SMD): 2.437, 95% confidence interval (CI): (1.265, 3.609), p < .001). For studies of serum samples detected by enzyme-linked immunosorbent assay (ELISA), subgroup analyses according to ethnicity, body mass index (BMI), sample size, detection method (high-performance liquid chromatography (HPLC) and ELISA), PCOS-to-control ratio and study quality displayed that high BPA levels were significantly associated with Caucasian PCOS patients (SMD: 0.615, 95% CI: (0.308, 0.922), p < .001), high BMI (SMD: 0.512, 95% CI: (0.180, 0.843), p = .002), high quality (SMD: 0.624, 95% CI: (0.391, 0.856), p < .001), and high HOMA-IR (SMD: 0.467, 95% CI: (0.121, 0.813), p = .008).
CONCLUSIONS: Serum BPA may be positively associated with women with PCOS and BPA might be involved in the insulin-resistance and hyperandrogenism of PCOS. More evidence from high quality studies, advanced detection methods, and larger cohorts for observational trials are needed to further confirm the association between BPA and PCOS.

Entities:  

Keywords:  Bisphenol A (BPA); meta-analysis; polycystic ovary syndrome (PCOS); systematic review

Mesh:

Substances:

Year:  2017        PMID: 29191127     DOI: 10.1080/09513590.2017.1405931

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  15 in total

1.  Bisphenol A correlates with fewer retrieved oocytes in women with tubal factor infertility.

Authors:  Areti Mina; Georgios Boutzios; Ioannis Papoutsis; George Kaparos; Panagiotis Christopoulos; Eleni Kousta; Minas Mastrominas; Sotirios Athanaselis; George Mastorakos
Journal:  Hormones (Athens)       Date:  2022-05-06       Impact factor: 2.885

2.  Association between CYP2E1 C-1054T and 96-bp I/D genetic variations and the risk of polycystic ovary syndrome in Chinese women.

Authors:  Y Pu; Q Liu; H Liu; H Bai; W Huang; M Xi; P Fan
Journal:  J Endocrinol Invest       Date:  2022-08-09       Impact factor: 5.467

Review 3.  The Role of Genetics, Epigenetics and Lifestyle in Polycystic Ovary Syndrome Development: the State of the Art.

Authors:  Vincenzina Bruni; Anna Capozzi; Stefano Lello
Journal:  Reprod Sci       Date:  2021-03-11       Impact factor: 3.060

4.  Buy-now-pay-later: Hazards to human and planetary health from plastics production, use and waste.

Authors:  Christos Symeonides; Manuel Brunner; Yannick Mulders; Priyanka Toshniwal; Matthew Cantrell; Louise Mofflin; Sarah Dunlop
Journal:  J Paediatr Child Health       Date:  2021-11       Impact factor: 1.929

Review 5.  Overview of air pollution and endocrine disorders.

Authors:  Philippa D Darbre
Journal:  Int J Gen Med       Date:  2018-05-23

6.  Bisphenol A exposure and type 2 diabetes mellitus risk: a meta-analysis.

Authors:  Semi Hwang; Jung-Eun Lim; Yoonjeong Choi; Sun Ha Jee
Journal:  BMC Endocr Disord       Date:  2018-11-06       Impact factor: 2.763

7.  Ion-Trap Mass Spectrometric Analysis of Bisphenol A Interactions With Titanium Dioxide Nanoparticles and Milk Proteins.

Authors:  Edward P C Lai; Hendrik Kersten; Thorsten Benter
Journal:  Molecules       Date:  2020-02-06       Impact factor: 4.411

Review 8.  Bisphenol A: an emerging threat to female fertility.

Authors:  Claudia Pivonello; Giovanna Muscogiuri; Antonio Nardone; Francesco Garifalos; Donatella Paola Provvisiero; Nunzia Verde; Cristina de Angelis; Alessandro Conforti; Mariangela Piscopo; Renata Simona Auriemma; Annamaria Colao; Rosario Pivonello
Journal:  Reprod Biol Endocrinol       Date:  2020-03-14       Impact factor: 5.211

Review 9.  Safeguarding Female Reproductive Health against Endocrine Disrupting Chemicals-The FREIA Project.

Authors:  Majorie B M van Duursen; Julie Boberg; Sofie Christiansen; Lisa Connolly; Pauliina Damdimopoulou; Panagiotis Filis; Paul A Fowler; Bart M Gadella; Jan Holte; Kersti Jääger; Hanna K L Johansson; Tianyi Li; Séverine Mazaud-Guittot; Anne-Simone Parent; Andres Salumets; Ana M Soto; Terje Svingen; Agne Velthut-Meikas; Eva Bay Wedebye; Yuling Xie; Martin van den Berg
Journal:  Int J Mol Sci       Date:  2020-05-01       Impact factor: 5.923

10.  Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies.

Authors:  Miguel A Sanchez-Garrido; Manuel Tena-Sempere
Journal:  Mol Metab       Date:  2020-02-05       Impact factor: 7.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.